264 related articles for article (PubMed ID: 12867066)
1. Antisense oligonucleotides for cancer therapy-an overview.
Stahel RA; Zangemeister-Wittke U
Lung Cancer; 2003 Aug; 41 Suppl 1():S81-8. PubMed ID: 12867066
[TBL] [Abstract][Full Text] [Related]
2. Antisense oligonucleotides: the state of the art.
Aboul-Fadl T
Curr Med Chem; 2005; 12(19):2193-214. PubMed ID: 16178780
[TBL] [Abstract][Full Text] [Related]
3. Antisense therapy in oncology: new hope for an old idea?
Tamm I; Dörken B; Hartmann G
Lancet; 2001 Aug; 358(9280):489-97. PubMed ID: 11513935
[TBL] [Abstract][Full Text] [Related]
4. Antisense oligonucleotides as therapeutics for malignant diseases.
Ho PT; Parkinson DR
Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689
[TBL] [Abstract][Full Text] [Related]
5. Antisense therapy in clinical oncology: preclinical and clinical experiences.
Tamm I; Wagner M
Mol Biotechnol; 2006 Jul; 33(3):221-38. PubMed ID: 16946452
[TBL] [Abstract][Full Text] [Related]
6. Antisense therapy in malignant diseases: status quo and quo vadis?
Tamm I
Clin Sci (Lond); 2006 Apr; 110(4):427-42. PubMed ID: 16526947
[TBL] [Abstract][Full Text] [Related]
7. Antisense protein kinase A RI alpha-induced tumor reversion: portrait of a microarray.
Cho-Chung YS
Biochim Biophys Acta; 2004 Mar; 1697(1-2):71-9. PubMed ID: 15023351
[TBL] [Abstract][Full Text] [Related]
8. Antisense therapy for cancer--the time of truth.
Jansen B; Zangemeister-Wittke U
Lancet Oncol; 2002 Nov; 3(11):672-83. PubMed ID: 12424069
[TBL] [Abstract][Full Text] [Related]
9. The therapeutic potential of antisense oligonucleotides.
Sharma HW; Narayanan R
Bioessays; 1995 Dec; 17(12):1055-63. PubMed ID: 8634067
[TBL] [Abstract][Full Text] [Related]
10. Antisense and/or immunostimulatory oligonucleotide therapeutics.
Agrawal S; Kandimalla ER
Curr Cancer Drug Targets; 2001 Nov; 1(3):197-209. PubMed ID: 12188879
[TBL] [Abstract][Full Text] [Related]
11. Preclinical and clinical pharmacology of antisense oligonucleotides.
Marcusson EG; Yacyshyn BR; Shanahan WR; Dean NM
Mol Biotechnol; 1999 Aug; 12(1):1-11. PubMed ID: 10554769
[TBL] [Abstract][Full Text] [Related]
12. Not nonsense but antisense--applications of antisense oligonucleotides in different fields of medicine.
Oberbauer R
Wien Klin Wochenschr; 1997 Jan; 109(2):40-6. PubMed ID: 9123943
[TBL] [Abstract][Full Text] [Related]
13. Antisense anticancer oligonucleotide therapeutics.
Wang H; Prasad G; Buolamwini JK; Zhang R
Curr Cancer Drug Targets; 2001 Nov; 1(3):177-96. PubMed ID: 12188878
[TBL] [Abstract][Full Text] [Related]
14. Antisense oligonucleotide therapy in cancer.
Stephens AC; Rivers RP
Curr Opin Mol Ther; 2003 Apr; 5(2):118-22. PubMed ID: 12772500
[TBL] [Abstract][Full Text] [Related]
15. [Basics of antisense oligonucleotide therapy and current therapeutical strategies in urology].
Kausch I; Böhle A
Aktuelle Urol; 2003 Dec; 34(7):458-68. PubMed ID: 14655082
[TBL] [Abstract][Full Text] [Related]
16. Targeting the expression of anti-apoptotic proteins by antisense oligonucleotides.
Delihas N
Curr Drug Targets; 2001 Jun; 2(2):167-80. PubMed ID: 11469717
[TBL] [Abstract][Full Text] [Related]
17. Antisense of oligonucleotides and the inhibition of oncogene expression.
Prins J; de Vries EG; Mulder NH
Clin Oncol (R Coll Radiol); 1993; 5(4):245-52. PubMed ID: 8398922
[TBL] [Abstract][Full Text] [Related]
18. [Antisense oligonucleotides are clinically tested. They inhibit the expression of disease-related genes].
Sommer W; Heilig M
Lakartidningen; 1999 Jan; 96(4):348-54. PubMed ID: 10024826
[TBL] [Abstract][Full Text] [Related]
19. Nucleic acid modulation of gene expression: approaches for nucleic acid therapeutics against cancer.
Nakata Y; Kim TK; Shetzline S; Gewirtz AM
Crit Rev Eukaryot Gene Expr; 2005; 15(2):163-82. PubMed ID: 16022634
[TBL] [Abstract][Full Text] [Related]
20. Antisense oligonucleotide therapy in urology.
Kausch I; Böhle A
J Urol; 2002 Jul; 168(1):239-47. PubMed ID: 12050550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
